Andrew Hartmann - 15 Feb 2023 Form 4 Insider Report for Varex Imaging Corp (VREX)

Role
SVP Sales & Marketing, Medical
Signature
/s/ Kimberley Honeysett, attorney-in-fact for Andrew Hartmann
Issuer symbol
VREX
Transactions as of
15 Feb 2023
Net transactions value
-$46,410
Form type
4
Filing time
17 Feb 2023, 16:13:58 UTC
Previous filing
13 Dec 2022
Next filing
12 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VREX Common Stock Options Exercise +1,623 +16% 11,682 15 Feb 2023 Direct F1
transaction VREX Common Stock Options Exercise +5,761 +49% 17,443 15 Feb 2023 Direct F1
transaction VREX Common Stock Tax liability $46,410 -2,466 -14% $18.82 14,977 15 Feb 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VREX Restricted Stock Units Options Exercise $0 -1,623 -100% $0.000000* 0 15 Feb 2023 Common Stock 1,623 Direct F1, F3
transaction VREX Restricted Stock Units Options Exercise $0 -5,761 -50% $0.000000 5,762 15 Feb 2023 Common Stock 5,761 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit converts into common stock on a one-for-one basis.
F2 These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.
F3 The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.
F4 These Restricted Stock Units granted on February 16, 2021 vest 50% on February 15, 2023 and 50% on February 15, 2025. Vested shares will be delivered to the reporting person upon vest date.